As cellular therapeutics move from small scale to large scale manufacturing, systems to allow for scalability while keeping safety and regulatory concerns managed become critical. Three dimensional culture in bioreactors with microcarriers has been evaluated as a means to reach this end. In this study, a novel bioreactor system (MAG 3L, PBS Biotech) was employed in conjunction with non-coated plastic microcarriers (Star Plus, Pall Medical) and xenogenic free medium containing human platelet lysate (Stemulate NH, Cook Regentec).
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Cytotherapy
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect